These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1386145)

  • 1. Preferential location of N-methyl-D-aspartate (NMDA) receptors on postsynaptic membranes and on non-noradrenergic nerve terminals of the rat brain cortex.
    Fink K; Blohm M; Molderings G; Bönisch H; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jun; 345(6):633-8. PubMed ID: 1386145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 envelope protein gp120 potentiates NMDA-evoked noradrenaline release by a direct action at rat hippocampal and cortical noradrenergic nerve endings.
    Pittaluga A; Raiteri M
    Eur J Neurosci; 1994 Nov; 6(11):1743-9. PubMed ID: 7874313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-methyl-D-aspartate (NMDA) receptor-mediated stimulation of noradrenaline release, but not release of other neurotransmitters, in the rat brain cortex: receptor location, characterization and desensitization.
    Fink K; Göthert M; Molderings G; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 1989 May; 339(5):514-21. PubMed ID: 2570360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.
    Mugnaini M; van Amsterdam FT; Ratti E; Trist DG; Bowery NG
    Br J Pharmacol; 1996 Nov; 119(5):819-28. PubMed ID: 8922727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cerebral hypoxia on NMDA receptor binding characteristics after treatment with 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) in newborn piglets.
    Fritz KI; Groenendaal F; McGowan JE; Mishra OP; Delivoria-Papadopoulos M
    Brain Res; 1996 Aug; 729(1):66-74. PubMed ID: 8874877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human brain N-methyl-D-aspartate receptors regulating noradrenaline release are positively modulated by HIV-1 coat protein gp120.
    Pittaluga A; Pattarini R; Severi P; Raiteri M
    AIDS; 1996 May; 10(5):463-8. PubMed ID: 8724036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubilization and partial purification of 3-((+-)-2-carboxypiperazine-4-yl)-[1,2-3H]propyl-1-phosphonic acid recognition proteins from rat brain synaptic membranes.
    Cunningham MD; Michaelis EK
    J Biol Chem; 1990 May; 265(14):7768-78. PubMed ID: 1970819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacological specificity of N-methyl-D-aspartate receptors in rat cerebral cortex: correspondence between radioligand binding and electrophysiological measurements.
    Grimwood S; Foster AC; Kemp JA
    Br J Pharmacol; 1991 Jun; 103(2):1385-92. PubMed ID: 1832067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-methyl-D-aspartate (NMDA)-stimulated noradrenaline (NA) release in rat brain cortex is modulated by presynaptic H3-receptors.
    Fink K; Schlicker E; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Feb; 349(2):113-7. PubMed ID: 8170496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presynaptic glutamate receptors regulate noradrenaline release from isolated nerve terminals.
    Wang JK; Andrews H; Thukral V
    J Neurochem; 1992 Jan; 58(1):204-11. PubMed ID: 1345765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of N-methyl-D-aspartate receptors in the rat striatum: effects of specific lesions on the [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid binding.
    Samuel D; Errami M; Nieoullon A
    J Neurochem; 1990 Jun; 54(6):1926-33. PubMed ID: 2159977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
    Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C
    J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous glycine modulates N-methyl-D-aspartate-evoked release of adenosine and [3H]noradrenaline from rat cortical slices.
    Craig CG; White TD
    Eur J Pharmacol; 1991 May; 197(1):1-7. PubMed ID: 1832638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid to rat brain membranes: a selective, high-affinity ligand for N-methyl-D-aspartate receptors.
    Murphy DE; Schneider J; Boehm C; Lehmann J; Williams M
    J Pharmacol Exp Ther; 1987 Mar; 240(3):778-84. PubMed ID: 3031274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of N-methyl-D-aspartate (NMDA)-stimulated noradrenaline release in rat brain cortex by presynaptic alpha 2-adrenoceptors.
    Fink K; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Oct; 348(4):372-8. PubMed ID: 7904051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the binding of [3H]-CGS 19755: a novel N-methyl-D-aspartate antagonist with nanomolar affinity in rat brain.
    Murphy DE; Hutchison AJ; Hurt SD; Williams M; Sills MA
    Br J Pharmacol; 1988 Nov; 95(3):932-8. PubMed ID: 2850065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-affinity uptake of noradrenaline in postsynaptic neurones.
    al-Damluji S; Krsmanovic LZ; Catt KJ
    Br J Pharmacol; 1993 Jun; 109(2):299-307. PubMed ID: 8358534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human immunodeficiency virus-1 protein transactivator of transcription up-regulates N-methyl-D-aspartate receptor function by acting at metabotropic glutamate receptor 1 receptors coexisting on human and rat brain noradrenergic neurones.
    Longordo F; Feligioni M; Chiaramonte G; Sbaffi PF; Raiteri M; Pittaluga A
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1097-105. PubMed ID: 16489129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of NMDA receptors labelled with [3H]3-((+-)-2-carboxypiperazin-4-yl) propyl-1-phosphonic acid ([3H]CPP): receptor status in Alzheimer's disease brains.
    Porter RH; Cowburn RF; Alasuzoff I; Briggs RS; Roberts PJ
    Eur J Pharmacol; 1992 Mar; 225(3):195-201. PubMed ID: 1387617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]CGP 39653: a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain.
    Sills MA; Fagg G; Pozza M; Angst C; Brundish DE; Hurt SD; Wilusz EJ; Williams M
    Eur J Pharmacol; 1991 Jan; 192(1):19-24. PubMed ID: 1674916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.